Differential neural circuitry behind autism subtypes with imbalanced social communicative and restricted repetitive behavior symptoms by Bertelsen, N. et al.
BIROn - Birkbeck Institutional Research Online
Bertelsen, N. and Isotta, L. and Jones, Emily J.H. and Lombardo, M.
(2021) Differential neural circuitry behind autism subtypes with imbalanced
social communicative and restricted repetitive behavior symptoms.
Communications Biology , ISSN 2399-3642. (In Press)
Downloaded from: http://eprints.bbk.ac.uk/id/eprint/43282/
Usage Guidelines:




Title:  Differential neural circuitry behind autism subtypes with imbalanced social-1 
communicative and restricted repetitive behavior symptoms  2 
 3 
  4 
Authors: Natasha Bertelsen1,2, Isotta Landi1, Richard A. I. Bethlehem3, Jakob Seidlitz4,5, Elena 5 
Maria Busuoli1,2, Veronica Mandelli1,2, Eleonora Satta1, Stavros Trakoshis1,6, Bonnie 6 
Auyeung7,8, Prantik Kundu9, Eva Loth10,11, Guillaume Dumas12, Sarah Baumeister13, Christian F. 7 
Beckmann14, Sven Bölte15,16,17, Thomas Bourgeron12, Tony Charman18, Sarah Durston19, 8 
Christine Ecker20, Rosemary J. Holt8, Mark H. Johnson21, Emily J. H. Jones22, Luke Mason22, 9 
Andreas Meyer-Lindenberg23, Carolin Moessnang23, Marianne Oldehinkel14,24, Antonio 10 
Persico25, Julian Tillmann18,26, Steven C. R., Williams27, Will Spooren28, Declan G. M. 11 
Murphy10,11, Jan K. Buitelaar14, the EU-AIMS LEAP group, Simon Baron-Cohen8, Meng-Chuan 12 
Lai8,29,30,31,32, & Michael V. Lombardo1,8* 13 
 14 
Affiliations:  15 
 16 
1 Laboratory for Autism and Neurodevelopmental Disorders, Center for Neuroscience and 17 
Cognitive Systems @UniTn, Istituto Italiano di Tecnologia, Rovereto (TN), Italy 18 
2 Center for Mind/Brain Sciences, University of Trento, Rovereto (TN), Italy 19 
3 Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom 20 
4 Department of Child and Adolescent Psychiatry and Behavioral Science, Children's 21 
Hospital of Philadelphia, Philadelphia, PA, USA 22 
5 Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA 23 
6 Department of Psychology, University of Cyprus, Nicosia, Cyprus 24 
7 Department of Psychology, School of Philosophy, Psychology, and Language Sciences, 25 
University of Edinburgh, Edinburgh, United Kingdom 26 
8 Autism Research Centre, Department of Psychiatry, University of Cambridge, 27 
Cambridge, United Kingdom 28 
9 Brain Mapping Unit, Department of Psychiatry, University of Cambridge, Cambridge, 29 
United Kingdom 30 
10 Sackler Institute for Translational Neurodevelopment, Institute of Psychiatry, Psychology 31 
and Neuroscience, King’s College London, London, United Kingdom 32 
11 Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, 33 
Psychology and Neuroscience, King’s College London, London, United Kingdom 34 
12 Human Genetics and Cognitive Functions, Institut Pasteur, UMR3571 CNRS, Université 35 
de Paris, Paris, France  36 
13 Child and Adolescent Psychiatry, Central Institute of Mental Health, Medical Faculty 37 
Mannheim, University of Heidelberg, Mannheim, Germany 38 
14 Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and 39 
Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands 40 
15 Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research; 41 
Department of Women’s and Children’s Health, Karolinska Institutet & Stockholm 42 
Health Care Services, Region Stockholm, Stockholm, Sweden 43 
16 Child and Adolescent Psychiatry, Stockholm Health Care Services, Stockholm, Sweden 44 
17  Curtin Autism Research Group, School of Occupational Therapy, Social Work and 45 
Speech Pathology, Curtin University, Perth, Australia 46 
 
 2
18 Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King’s 47 
College London, London, United Kingdom 48 
19 Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center 49 
Utrecht, Utrecht, The Netherlands 50 
20 Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, 51 
University Hospital Frankfurt am Main, Goethe University, Frankfurt, Germany 52 
21 Department of Psychology, University of Cambridge, Cambridge, United Kingdom 53 
22 Centre for Brain and Cognitive Development, Birkbeck, University of London, Henry 54 
Wellcome Building, London, United Kingdom 55 
23 Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical 56 
Faculty Mannheim, University of Heidelberg, Mannheim, Germany 57 
24 Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash 58 
University, Victoria, Australia 59 
25 Child and Adolescent Neuropsychiatry Unit, Gaetano Martino University Hospital, 60 
University of Messina, Messina, Italy 61 
26 Department of Applied Psychology: Health, Development, Enhancement, and 62 
Intervention, University of Vienna, Vienna, Austria 63 
27 Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, 64 
King’s College London, London, United Kingdom  65 
28 Roche Pharma Research and Early Development, Neuroscience, Ophthalmology and 66 
Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland 67 
29 The Margaret and Wallace McCain Centre for Child, Youth & Family Mental Health, 68 
Azrieli Adult Neurodevelopmental Centre, and Campbell Family Mental Health Research 69 
Institute, Centre for Addiction and Mental Health, Toronto, Canada 70 
30 Department of Psychiatry and Autism Research Unit, The Hospital for Sick Children, 71 
Toronto, Canada 72 
31 Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Canada 73 
32 Department of Psychiatry, National Taiwan University Hospital and College of Medicine, 74 
Taipei, Taiwan 75 
 76 
* Corresponding Author:  Michael V. Lombardo (michael.lombardo@iit.it) 77 
 78 
 79 





Social-communication (SC) and restricted repetitive behaviors (RRB) are autism diagnostic 83 
symptom domains. SC and RRB severity can markedly differ within and between individuals 84 
and may be underpinned by different neural circuitry and genetic mechanisms. Modeling SC-85 
RRB balance could help identify how neural circuitry and genetic mechanisms map onto such 86 
phenotypic heterogeneity. Here we developed a phenotypic stratification model that makes 87 
highly accurate (97-99%) out-of-sample SC=RRB, SC>RRB, and RRB>SC subtype predictions. 88 
Applying this model to resting state fMRI data from the EU-AIMS LEAP dataset (n=509), we 89 
find that while the phenotypic subtypes share many commonalities in terms of intrinsic 90 
functional connectivity, they also show replicable differences within some networks compared to 91 
a typically-developing group (TD). Specifically, the somatomotor network is hypoconnected 92 
with perisylvian circuitry in SC>RRB and visual association circuitry in SC=RRB. The SC=RRB 93 
subtype show hyperconnectivity between medial motor and anterior salience circuitry. Genes 94 
that are highly expressed within these networks show a differential enrichment pattern with 95 
known autism-associated genes, indicating that such circuits are affected by differing autism-96 
associated genomic mechanisms. These results suggest that SC-RRB imbalance subtypes share 97 
many commonalities, but also express subtle differences in functional neural circuitry and the 98 




Autism spectrum disorder (ASD) is a clinical consensus label used to characterize 101 
individuals with a collection of early onset developmental difficulties in the domains of social-102 
communication (SC) and restricted repetitive behaviors (RRB)1,2. The single diagnostic label of 103 
autism helps many individuals in a variety of ways by being incorporated into a sense of identity, 104 
explaining challenging aspects of life, and/or enabling access to services. However, the diagnosis 105 
also encapsulates a vast amount of multi-scale heterogeneity. In the face of such heterogeneity, 106 
future translational research must develop a deeper understanding of how biological mechanisms 107 
affect individuals and must develop more personalized approaches towards interventions to help 108 
facilitate positive outcomes3.  109 
 110 
Because heterogeneity manifests across every scale from phenome to genome, it is 111 
important to understand whether top-down phenotypic stratifications may be useful. For 112 
example, there is evidence to suggest that important phenotypic stratifications could be made 113 
based on the balance between SC and RRB domains. Prior work has suggested that SC and RRB 114 
domains could be fractionable at behavioral4 and neural levels5–7 and potentially underpinned by 115 
different genetic mechanisms8–11. However, robust evidence of this phenotypic fractionation 116 
mapping onto differential neural circuitry and genomic mechanisms has yet to be identified. The 117 
potential multi-scale fractionation of these domains provides a strong starting point for 118 
understanding how multi-scale heterogeneity manifests in autism from genome to phenome.  119 
 120 
In this work, we test the hypothesis that subtyping individuals by the degree of SC-RRB 121 
balance can help identify differential biological mechanisms. Past research utilizing ‘gold 122 
standard’ diagnostic tools such as the Autism Diagnostic Observation Schedule (ADOS) and the 123 
Autism Diagnostic Interview-Revised (ADI-R) (e.g., 12–14) have suggested the presence of 3 SC-124 
RRB balance subtypes: 1) medium to high levels of both SC and RRB severity (SC=RRB); 2) 125 
medium to high SC severity and comparatively lower RRB severity (SC>RRB); and 3) medium 126 
to high RRB severity and comparatively lower SC severity (RRB>SC). These subtypes might be 127 
underpinned by a common pathway if they showed similar neural circuits and genomic 128 
mechanisms that differ from a typically-developing (TD) comparison group. However, based on 129 
the hypothesis that SC and RRB domains are fractionable across multiple levels, it could be that 130 
these subtypes diverge onto multiple atypical pathways from genome to phenome15 (Figure 1). 131 
This idea has not yet been tested with respect to macroscale neural circuitry and its link to 132 
functional genomic mechanisms. Here we evaluate how SC-RRB balance subtypes link up to 133 
differential macroscale connectome phenotypes, measured with resting state fMRI (rsfMRI) 134 
functional connectivity. Functional connectivity networks are known to be linked to underlying 135 
transcriptomic mechanisms, particularly with regards to the spatial patterning of gene expression 136 
across the brain (e.g., 16–18). Given that subtypes could exhibit different functional connectome 137 
phenotypes, we leverage the link between macroscale rsfMRI functional networks and 138 
transcriptomic mechanisms to better understand whether autism-relevant functional genomic 139 
mechanisms differentially affect such phenotypes.  140 
 141 
To test these ideas, we developed a stratification approach that subtypes individuals 142 
based on the within-individual balance between SC versus RRB severity, as measured by ADI-R 143 
data from thousands of individuals (n=2,628) obtained from the National Database for Autism 144 
Research (NDAR) (https://nda.nih.gov). This approach can be used to make highly accurate out-145 
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of-sample subtype predictions and thus can be applicable to any new dataset where ADI-R data 146 
is collected. We applied this SC-RRB balance stratification model to the deeply phenotyped EU-147 
AIMS LEAP dataset19–21 to examine how functional connectivity may differ between SC-RRB 148 
balance subtypes or relative to a typically-developing (TD) comparison group. While SC-RRB 149 
balance subtypes are important to test, it may be also useful to consider overall level of SC and 150 
RRB severity as important and to characterize this severity in a continuous manner. Thus, we 151 
also evaluate other possible continuous/dimensional models that examine SC and RRB 152 
separately as well as using SC-RRB balance score as a continuous variable. Finally, in order to 153 
link functional connectome phenotypes to autism-associated genes, we utilize the Allen Institute 154 
Human Brain Atlas22,23 to identify genes whose spatial expression pattern is highly similar to 155 
macroscale functional networks that differ amongst the SC-RRB subtypes. These functional 156 
network-relevant gene lists are then investigated for enrichment in a variety of autism-associated 157 
gene lists derived from evidence at genetic or transcriptomic levels. This will allow for tests of 158 
the hypothesis that subtype disruption of imaging-derived phenotypes preferentially occurs to 159 
macroscale networks with high levels of gene expression of autism-associated genes24. This 160 
approach will also allow us to test whether autism-associated genes affect networks similarly or 161 





Highly accurate out-of-sample prediction of SC-RRB balance subtypes 167 
 168 
 In our first set of analyses, we sought to develop a model to predict ADI-R SC-RRB 169 
balance subtypes from the NDAR datasets. Relatively equal Discovery (n=889) and Replication 170 
(n=890) datasets were partitioned from the total n=1,781 individuals in NDAR and this split into 171 
Discovery and Replication was balanced as a function of the originating datasets and sex. Using 172 
z-normalized difference scores, we split the dataset into SC=RRB, SC>RRB, and RRB>SC 173 
subtypes (Figure 2). Importantly, the subtype labels were first defined separately in Discovery 174 
and Replication sets based on the statistical norms (i.e. mean and SD) estimated on each set. This 175 
ensures that the definition of the labels in each set is done independently of the other. If the 176 
statistical norms for the computation of z-normalized difference scores (e.g., mean and SD) are 177 
highly similar between Discovery and Replication, then the subtyping model learned from the 178 
Discovery set will likely be highly generalizable and produce high accuracy values in the 179 
Replication set. However, if the statistical norms are highly different between Discovery and 180 
Replication, the model learned from Discovery data will not generalize well to the labels in the 181 
Replication set and would thus produce poor out-of-sample prediction accuracy.  182 
 183 
Applying this approach across a range of z-thresholds (e.g., z = 0.5 up to z =1 in steps of 184 
0.1), we find that out-of-sample prediction accuracy is very high (e.g., 97-99%). The reason for 185 
this high accuracy is visually evident in the high degree of similarity in distributions of 186 
Discovery and Replication sets in the scatterplots in Figure 2A. Examination of sex across these 187 
subtypes did not yield any significant between-subtype differences (Discovery: χ2 = 1.91; p = 188 
0.38; Replication: χ2 = 3.50; p = 0.17), with a 3:1 to 5:1 sex ratio of males to females. Subtypes 189 
did differ in age at the time of ADI-R interview, with the SC>RRB group being younger than the 190 
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other subtypes (Discovery: F(2,886) = 10.61, p = 2.77e-5; Replication: F(2,887) = 10.80, p = 191 
2.31e-5). See Table 1 for descriptive statistics.  192 
 193 
Contrasting this z-score approach to subtyping with unsupervised clustering methods 194 
(Supplementary Figure 1) that use static tree cut heights along with internal cluster validation 195 
metrics for choosing the optimal number of clusters, we found that such SC-RRB balance 196 
subtypes are not easily identifiable in a consistent fashion across Discovery and Replication 197 
cohorts with such blind methods. However, when using an automated dynamic hybrid tree-198 
cutting algorithm that adaptively modifies cutting the dendrogram at different heights28,29, we are 199 
able to get relatively close to finding similar partitions in Discovery (6 subtypes) versus 200 
Replication (7 subtypes) sets (Supplementary Figure 2).  201 
 202 
Replicable subtype-specific functional connectivity differences  203 
 204 
We next evaluated whether such SC-RRB balance subtypes are differentiated from TD 205 
comparison groups in rsfMRI functional connectivity. Because subtypes are defined based on 206 
thresholding the z-normalized SC-RRB difference score, we identified ‘consensus edges’ as 207 
functional connectivity differences between the autism subtype versus TD that consistently 208 
appear across every z-threshold examined. Figure 3 summarizes the consensus edges in each 209 
subtype for both the LEAP Discovery and Replication sets. Relative to the TD group, the 210 
SC=RRB subtype is characterized by on-average hyperconnectivity between the anterior salience 211 
network (IC07) and a medial motor network (IC13) (effect sizes at z=1 threshold: Discovery 212 
Cohen’s d = 0.36; Replication Cohen’s d = 0.51; repBF = 390) as well as hypoconnectivity 213 
between visual association (IC03) and somatomotor (IC12) networks (effect sizes at z=1 214 
threshold: Discovery Cohen’s d = -0.41; Replication Cohen’s d = -0.36; repBF = 16). The 215 
somatomotor network was also hypoconnected in SC>RRB relative to TD, but with the bilateral 216 
perisylvian (IC17) network (effect sizes at z=1 threshold: Discovery Cohen’s d = -0.40; 217 
Replication Cohen’s d = -0.41; repBF = 23). In contrast to comparing autism subtypes to TD, we 218 
also directly compared SC=RRB versus SC>RRB. This analysis did not yield any significant 219 
replicable differences, indicating that while these subtypes can replicably differ relative to a TD 220 
comparison group in qualitatively unique ways, the difference between each other may not be 221 
replicably large enough to detect at current sample sizes (effect sizes for z=1 threshold: IC07-222 
IC13, Discovery Cohen’s d = 0.10, Replication Cohen’s d = 0.01; IC03-IC12, Discovery 223 
Cohen’s d = -0.10, Replication Cohen’s d = -0.13; IC12-IC17, Discovery Cohen’s d = 0.27, 224 
Replication Cohen’s d = 0.11). For the full set of statistical results at z=1 threshold across all 225 
comparisons see Supplementary Data 1. Thus, the connectivity results suggest a mixture of some 226 
overlap in affected networks in both subtypes (e.g., IC12), alongside some qualitative specificity 227 
of networks affected in only one of the subtypes (e.g., IC03, IC07, IC13 for SC=RRB; IC17 for 228 
SC>RRB). Importantly, this subtype-distinctiveness is subtle and relative to TD, but does not 229 
heavily differ when subtypes are directly compared to each other. 230 
 231 
Because the subtyping approach uses the difference score between SC and RRB, this 232 
metric does not distinguish individuals by overall level of severity. For example, an individual 233 
with low SC and RRB severity is treated similarly to an individual with high SC and RRB 234 
severity. This leaves open the possibility that degree of severity on a continuum from high to low 235 
could also explain variability in functional connectivity. To test this hypothesis, we constructed a 236 
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dimensional model to predict connectivity strength from SC or RRB severity as a continuous 237 
variable. However, there were no instances whereby SC or RRB severity as a continuous 238 
measure could replicably predict connectivity strength. Similarly, when using the z-normalized 239 
SC-RRB difference score as a continuous variable, we also found no replicable significant 240 
effects on connectivity. For the full set of statistics see Supplementary Data 1. These results 241 
provide a dimensional model contrast to the categorical subtyping approach and suggests that 242 
modeling continuous SC or RRB variability may be less sensitive as a predictor of functional 243 
connectivity compared to SC-RRB balance subtypes. 244 
 245 
Divergent functional genomic underpinnings of subtype-specific neural circuitry 246 
 247 
 In the next analysis, we asked if known autism-associated genes are enriched amongst 248 
genes known to be highly expressed in these subtype-associated rsfMRI networks. We first 249 
identified lists of genes whose spatial expression topology in the Allen Institute Human Brain 250 
Atlas22 is similar to rsfMRI connectivity networks23 that show replicable subtype differences. 251 
Once a set of genes are predicted to underpin such rsfMRI networks, we then asked whether 252 
those genes are highly overlapping with known sets of functional genomic mechanisms linked to 253 
autism (see Figure 4A for a visual representation of the analysis approach and Supplementary 254 
Data 2 for the full set of gene lists used in these analyses). Underscoring functional genomic 255 
overlap between the subtypes, all networks except for IC07 were enriched for a variety of similar 256 
autism-associated gene lists – such as, high penetrance rare de novo protein truncating variants 257 
(IC03, IC17), genes associated with autism from the SFARI Gene database (IC03, IC12, IC17), 258 
genes and co-expression modules that are downregulated in expression (IC1, IC03, IC12, IC17), 259 
and genes differentially expressed in excitatory and inhibitory neurons (IC03, IC12, IC17) and 260 
astrocytes (IC17). Despite this overlap, our next analysis focused on genes that were specific to 261 
networks affecting only one of the subtypes. To achieve this aim, we removed genes that showed 262 
high levels of expression across multiple networks. The resulting lists are genes that are 263 
expressed specifically in only one of the networks affecting the SC-RRB imbalance subtypes. 264 
This analysis revealed that genes expressed SC>RRB-affected networks (i.e. specifically IC17) 265 
are enriched for SFARI ASD genes, autism-downregulated co-expression modules, and genes 266 
differentially expressed in excitatory and inhibitory neurons and astrocytes. In contrast, genes 267 
expressed within SC=RRB-affected networks (i.e. specifically IC03, IC13, and IC07) are 268 
enriched only for genes downregulated in expression in autism. Thus, much like the connectivity 269 
results, these results implicate a mixture of overlap as well as some specificity in the genomic 270 





In this work, we examined how autism SC-RRB balance subtypes are atypical at the level 276 
of macroscale neural circuitry measured with rsfMRI. Prior work has theorized that the core 277 
dyad of SC and RRB is fractionable at behavior, neural, and genetic levels4–14. However, it is 278 
unclear whether the road from genome to phenome (e.g., Figure 1) is one that converges on a 279 
common pathway or is one of multiple pathways15. Here we find evidence consistent with a 280 
mixture of both common and multiple pathways. Consistent with the common pathway 281 
hypothesis, we first find no evidence of strong between-subtype differences in autism when 282 
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subtypes are directly compared to each other. Rather, all replicable differences in functional 283 
connectivity appear when subtypes are compared to a TD comparison group. Also consistent 284 
with the idea of commonalities between the subtypes is the shared effect of somatomotor 285 
network hypoconnectivity with other networks. Gene expression decoding analysis of individual 286 
networks also showed some commonalities in enrichments with autism-associated gene lists.  287 
 288 
Despite these commonalities, there was also evidence for subtle distinctions between the 289 
subtypes. First, the edges identified as replicably different between the subtypes relative to TD 290 
were never the same for SC=RRB and SC>RRB subtypes. This effect indicates that relative to 291 
the TD norm, subtle but replicable on-average differences in network connectivity exist. This 292 
highlights how even though functional neural circuitry organization appears to be mostly shared 293 
between the subtypes, each subtype diverges slightly but also uniquely from typical development 294 
in their functional organization. It is possible that these on-average subtype differences relative 295 
to TD are driven by a smaller subset of individuals within the subtypes with the most dramatic 296 
differences from TD. However, it is also possible that phenotypic variability within our subtypes 297 
might result not simply from distinct neurocircuitry abnormalities but from more complex and 298 
subtle combinations of shared and divergent neurocircuits affecting the balance between 299 
symptom domains. Second, upon isolating the genes expressed specifically within subtype-300 
specific networks, we find a different pattern of autism-associated gene enrichment. Thus, rather 301 
than implicating a commonality in the genomic mechanisms that underpin different subtypes, 302 
this effect is consistent with the idea that some of the subtype-relevant genomic mechanisms 303 
differentially affect specific neural circuits such as perisylvian, visual association, or medial 304 
motor networks. 305 
 306 
Regarding the importance of specific networks identified in our analyses, the 307 
somatomotor network (IC12) has been implicated in past work on autism. Somatosensory areas 308 
have been shown to be some of the most informative regions in prior case-control classifier 309 
studies using rsfMRI data45. Additionally, prior case-control analyses of the EU-AIMS LEAP 310 
dataset find that somatomotor areas show reduced degree centrality and autism-related 311 
hyperconnectivity with cerebellar networks21,30. However, the lack of somatomotor 312 
hypoconnectivity with visual association or perisylvian networks in prior case-control studies 313 
highlights the potential importance and added value of subtyping for revealing more subtle 314 
effects that can be masked with case-control contrasts. The perisylvian network that is 315 
hypoconnected with somatomotor circuitry in SC>RRB overlaps with a variety of areas 316 
implicated in early development of autism, particularly for auditory processing and language46–317 
50. Integration of information processing between this network and others that play a role in 318 
embodied somatosensory and social cognitive processing51,52, such as the somatomotor network 319 
(IC12), could be important for explaining the more pronounced difficulties these individuals 320 
have within SC compared to RRB. Somatomotor hypoconnectivity with perisylvian auditory and 321 
visual association circuitry could also be important for pointing towards atypical multisensory 322 
integration that has been documented in autism53,54, particularly with regards to auditory-323 
somatosensory55 and visual-somatomotor integration56–60.  324 
 325 
In addition to somatomotor hypoconnectivity, we also observed a medial motor network 326 
which was hyperconnected to the anterior salience network in the SC=RRB subtype. The 327 
additional implication of another motor-relevant networks in this subtype underscores the 328 
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importance of motor circuitry61–63 and visual-motor integration atypicalities in autism56–60. The 329 
anterior salience network has also been identified in prior case-control studies. In younger 330 
cohorts, anterior salience areas are hyperconnected64,65, while in older cohorts, hypoconnectivity 331 
is observed66. While age could be a factor in explaining the discrepant findings from prior work, 332 
it likely cannot explain the SC=RRB hyperconnectivity finding. Here we age-matched the groups 333 
and additionally included age as a covariate in the statistical model. EU-AIMS LEAP also 334 
samples from a wide age range from 6 to 30 years of age, enabling the sample to include younger 335 
and older ages covered by prior work. Thus, age may not be the only explanation for salience 336 
network hyperconnectivity. Rather, this work suggests that SC-RRB heterogeneity and the 337 
presence of this balanced subtype could also drive such effects in case-control comparisons, 338 
particularly if the sample is enriched with this particular subtype. 339 
 340 
We also identified autism-relevant genomic underpinnings behind these subtype-specific 341 
rsfMRI networks. Genes specific to SC>RRB networks are enriched for a number of genomic 342 
mechanisms linked to autism such as genes differentially expressed in excitatory and inhibitory 343 
neurons and astrocytes, downregulated co-expression modules, and high-risk genetic mutations 344 
associated with autism. These genomic underpinnings suggest that specific neuronal cell types 345 
involved in cortical excitation-inhibition balance67,68 may be especially important for the 346 
SC>RRB subtype. This effect also partially corroborates evidence suggesting that excitatory 347 
neurons are affected in specific types of autistic individuals that differ in patterns of clinical 348 
severity43. In contrast, SC=RRB networks lacked similar kinds of enrichments, suggesting that 349 
differing functional genomic mechanisms may be linked to this subtype.  350 
 351 
Another important finding from the current work is the absence of replicable connectivity 352 
effects in simplistic models that treat SC and RRB separately as continuous predictors. These 353 
findings suggest that continuous variation (i.e. severity) within each domain separately may not 354 
have large impact on explaining variation in functional connectivity. Rather, the SC-RRB 355 
balance subtyping approach of jointly considering the unique mixture of both SC and RRB 356 
within an individual as a means to then categorically split the autism population into subtypes, 357 
could be a more fruitful first pass approach for explaining connectivity differences.  For 358 
example, other work also suggests that categorical factors may be mixed within participants in a 359 
mosaic fashion, whereby different individuals will have different mixtures of continuous 360 
differences along the factors69. This idea of a blend between both categorical and dimensional 361 
explanations for connectivity can be seen in work showing that etiologically distinct mechanisms 362 
known to cause autism result in continuous differentiation along a manifold landscape of 363 
functional connectivity70. Thus, further work might expand on categorical distinctions put forth 364 
by SC-RRB balance models to explain continuous variability within such subtypes. 365 
 366 
There are certain limitations and caveats that need to be discussed. First, the threshold for 367 
the z-score cutoff to define subtypes could be viewed as arbitrary. However, to guard against this 368 
issue, we re-ran the analysis across a range of thresholds from z=0.5 to z=1 and showed effects 369 
that are robust to the threshold used to label the subtypes. Accuracy for out-of-sample 370 
predictions is also high regardless of the threshold. This effect occurs largely because the data 371 
distributions and statistics used for the z-normalization are highly similar across large NDAR 372 
Discovery and Replication sets. In a situation where the data distributions were not similar, this 373 
high out-of-sample prediction accuracy would not have been obtained or may have fluctuated 374 
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more substantially at different thresholds. Thus, while the choice of a threshold may not be well 375 
defined, any choice within the range we have analyzed of z=0.5 to z=1, will yield highly 376 
consistent results that are not biased by the choice of a threshold. The fact that the data 377 
distributions and sample statistics used for the z-normalization were so similar across well-378 
matched NDAR Discovery and Replication sets allows for high-confidence that the large NDAR 379 
dataset is likely very close in accurately estimating the true population parameters, and this 380 
allows for the high degree of replicability and robustness of the subtyping approach. Second, the 381 
distinctions between these subtypes are not demarcated by large categorical separations. As such, 382 
when we applied other canonical unsupervised clustering methods to the data, such methods 383 
were not able to consistently identify the same subtypes in independent datasets (Supplementary 384 
Figure 1). An automated dynamic hybrid tree-cutting method to apply to hierarchical 385 
clustering28,29 was however, close to deriving relatively similar subtypes across Discovery and 386 
Replication sets (Supplementary Figure 2). Future work could explore the utility of this approach 387 
and the consensus subtypes derived from independent datasets with this methodology. However, 388 
the lack of very large separations between the boundaries for different subtypes of autistic 389 
individuals likely means that a more nuanced and theory-driven approach may be more fruitful 390 
than blind unsupervised approaches. Third, the RRB>SC group was not highly prominent in the 391 
EU-AIMS LEAP cohort. This observation is likely due to the fact that NDAR includes studies 392 
that more heavily sample individuals from the population with higher RRB severity relative to 393 
EU-AIMS LEAP. For example, ADOS CSS scores for RRB are higher in NDAR than in LEAP 394 
(see Tables 1-2). Because NDAR pools from a much wider range of studies in different contexts 395 
compared to EU-AIMS LEAP, this could be an explanation for this difference. Fourth, direct 396 
comparisons of functional connectivity between SC=RRB and SC>RRB subtypes did not yield 397 
as large or replicable differences as when the subtypes are compared to TD. Thus, while there are 398 
unique consensus edges that appear when the autism subtypes are compared to TD, this result 399 
should not be taken to imply that the subtypes themselves are also highly different from each 400 
other. A likely reason for why these differences manifest when compared to TD but not when 401 
subtypes are compared directly may be due to effects driven by further subsets of individuals 402 
nested within the larger SC=RRB and SC>RRB subtypes. Alternatively, it could be that the SC-403 
RRB subtyping approach does not allow for parsing apart the mechanisms that clearly 404 
distinguish different autistic individuals from each other. If autistic individuals are mosaics of 405 
many complex etiological mechanisms and those mechanisms have different effects on 406 
functional connectivity, then it may be that models quantifying such etiological mixtures may be 407 
better models of functional connectivity variation69,70. These individuals at the extremes of the 408 
functional connectivity distributions likely drive the on-average differences from TD. Future 409 
work that digs further into more granular divisions of the population may likely identify much 410 
larger differences when autism subtypes are compared directly. Fifth, we also discovered that 411 
dimensional models using continuous SC and RRB severity did not uncover any replicable 412 
associations with functional connectivity strength. This result could suggest that dimensional 413 
models that use continuous severity from the ADI-R are less effective than the subtyping 414 
approach. However, it could also be that dimensional models might be more sensitive with other 415 
measures of symptomatology (e.g., ADOS, SRS). Sixth, the subtyping here is based on the ADI-416 
R. ADI-R is a commonly used ‘gold standard’ diagnostic instrument to aid clinical judgment 417 
regarding an autism diagnosis. However, other measures such as the ADOS could also have been 418 
used. For our purposes in this study, we chose to utilize the ADI-R over the ADOS due to the 419 
fact that participants come from a wide age range, and the ADOS would assess current 420 
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symptomatology of the individual. If age has an effect on symptomatology71–73, then this could 421 
potentially bias the subtyping approach depending on the composition of the sample. On the 422 
other hand, because the ADI-R ‘diagnostic algorithm’ utilizes items that focus on early 423 
developmental and ‘most severe in lifetime’ symptomatology, we do not know how the 424 
individual might have changed across the lifespan of development. Additionally, it may be that 425 
measures of current symptomatology have a stronger association with measures of current 426 
functional connectivity than early childhood and lifetime snapshots of severity provided by the 427 
ADI-R. Future work that looks at how these ADI-R-derived SC-RRB balance subtypes might 428 
change over time would be informative from a developmental angle. It would also be important 429 
to investigate how observational measures such as the ADOS might perform as measures of 430 
symptomatology, especially if conducted within a restricted age range. Future work might also 431 
expand beyond cardinal diagnostic features and look into SC and RRB measured as quantitative 432 
autistic traits that expand beyond diagnostic features. 433 
 434 
 In conclusion, we have shown that SC-RRB balance can point to different macroscale 435 
functional connectivity phenotypes and potentially different genomic mechanisms that may 436 
underpin such phenotypes. While the divisions between these subtypes at the phenotypic level 437 
are not dramatically evident as categorical differences, at the level of macroscale neural circuitry, 438 
there is evidence to suggest that these SC-RRB subtypes are different when compared to the TD 439 
population. Future work to study these fractionable subtypes in an a-priori fashion will benefit 440 
from the use of our simple and supervised subtyping model and will further facilitate our 441 






NDAR Datasets 448 
 449 
For the initial set of analyses to derive the approach to characterizing SC and RRB 450 
symptom domains, we utilized ADI-R from the National Database for Autism Research 451 
(NDAR). Because individuals can differ over the lifespan with regard to current symptom 452 
presentation, we opted for using the ADI-R (‘diagnostic algorithm’ scores) as the measure of 453 
symptomatology because it allows for assessment of symptoms at similar ages regardless of the 454 
age of the participant at the time of testing. This is an important point within the context of the 455 
current study, whereby the age range of the follow-up sample (i.e. EU-AIMS LEAP) is notably 456 
wide (i.e. 6-30 years). Within the SC domain, many items are rated based on presentation around 457 
4-5 years of age. This is required because such items probe behaviors that are developmentally 458 
most appropriate in typical development around this point in the lifespan and the absence of such 459 
behaviors in autistic individuals is of diagnostic importance. In contrast, for many types of RRB 460 
domain items, the presence rather than the absence of such behaviors is of diagnostic importance 461 
for autism. For these items, the behaviors could occur at any point during the lifespan and are not 462 
developmentally restricted to a specific age range.   463 
 464 
On December 13, 2019 we conducted a search of NDAR to extract all datasets utilizing 465 
the ADI-R25. This resulted in 60 independent datasets totaling 2,628 unique individuals. From 466 
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here, we filtered for all individuals who had data for the verbal communication items (e.g., 467 
acquisition of words, phrases, social verbalization, chit-chat, reciprocal conversation), leaving a 468 
total of 1,781 individuals across 57 independent datasets. Within each of these 57 datasets, we 469 
randomly split the dataset in half to achieve independent Discovery and Replication sets that are 470 
balanced across the 57 datasets and by sex (Discovery n=889, mean age = 8.91 years, SD age = 471 
5.26 years, 77% male; Replication n=890, mean age = 8.89 years, SD age = 5.37 years, 77% 472 
male). See Table 1 for characteristics of the NDAR Discovery and Replication sets. ADI-R item-473 
level data was used to rescore algorithm totals according to the DSM-526 symptom dyad of 474 
social-communication (SC) and restricted repetitive behavior (RRB) domains. SC is comprised 475 
of 3 subscales (A1, A2, A3), while RRB is comprised of 4 subscales (B1, B2, B3, B4). See 476 
Supplementary Table 1 for how items break down into each domain and subscale within a 477 
domain. Only item scores of 0 to 3 (indicating increasing SC or RRB symptom severity) were 478 
utilized, while scores of 6 to 9 (dummy scores, not indicating symptom severity) were not used. 479 
Scores of 3 were kept as is (i.e. not converted to 2 as would typically occur when scoring the 480 
ADI-R algorithm) in order to retain information about severity conveyed by the difference 481 
between a score of 2 versus 3. Because the number of items in each subscale can vary depending 482 
on a person’s age (see Supplementary Table 1) and by the number of items with possible scores 483 
of 0 to 3, we used percentage scores in order to ensure that the estimates of severity on each 484 
subscale are on a comparable scale across individuals. These percentage scores for each domain 485 
subscale were then summed and scaled by number of subscales to achieve the final domain total 486 
percentage severity.  487 
 488 
Subtyping Analyses 489 
 490 
To label subtypes by SC-RRB balance, we first computed difference scores between SC 491 
and RRB to estimate the level of SC-RRB balance, whereby values above 0 indicate an 492 
individual with higher SC versus RRB (SC>RRB), whereas values below 0 indicate the reverse 493 
(RRB>SC). These SC-RRB difference scores were then z-normalized using the mean and 494 
standard deviation estimated separately for Discovery and Replication sets. A z-score cutoff was 495 
used to derive subtype labels. Individuals falling above the z-cutoff (e.g., z>1) were labeled as 496 
SC>RRB, while individuals falling below the negative value of the z-cutoff (e.g., z<-1) were 497 
labeled as RRB>SC. All individuals between the z-cutoffs were considered SC=RRB. Because 498 
the choice of a z-cutoff is arbitrary, we ran all analyses across a range of z-thresholds from z=0.5 499 
to z=1, in steps of 0.1. This approach allows us to report results across thresholds rather than 500 
using only one arbitrarily defined threshold. For the later functional connectivity analyses, this 501 
approach also allowed us to identify a consensus result which is consistent irrespective of the z-502 
threshold used to label subtypes. To make out-of-sample predictions, we used the mean and SD 503 
norms estimated from the NDAR Discovery set to z-score and label individuals in the NDAR 504 
Replication set. These predicted labels on the Replication set were then compared to the actual 505 
subtype labels computed using the mean and SD norms derived from the Replication set itself. 506 
To make subtype predictions in the EU-AIMS LEAP dataset, we combined both NDAR 507 
Discovery and Replication datasets into one large dataset. From this dataset, norms for the mean 508 
and standard deviation were computed (mean = 0.01045243, SD = 0.19482749) and used for the 509 
z-scoring procedure. SC-RRB difference z-scores were then computed and a z-threshold was 510 




In addition to this SC-RRB difference z-score subtyping approach, we also used other 513 
unsupervised clustering methods for identifying subtypes. These methods utilize agglomerative 514 
hierarchical clustering with Euclidean distance and the ward.D2 method. The optimal number of 515 
clusters was determined by a majority vote of 23 different metrics for determining the optimal 516 
number of clusters (e.g., using the NbClust library in R)27. With another approach, we ran the 517 
same hierarchical clustering analyses, but cut dendrograms to define subtypes using a dynamic 518 
hybrid tree cut algorithm, as utilized in past work28,29.  519 
 520 
EU-AIMS LEAP Dataset  521 
 522 
The EU-AIMS LEAP data comes from a large multisite European initiative with the aim 523 
of identifying biomarkers for ASD19. In this study, EU-AIMS LEAP data is utilized to examine 524 
how SC-RRB balance subtypes may differ in intrinsic functional connectomic organization using 525 
rsfMRI data. rsfMRI data from EU-AIMS LEAP has been analyzed for case-control differences 526 
in prior work21,30. EU-AIMS LEAP recruited 437 individuals with ASD and 300 TD individuals, 527 
both male and female, aged between 6 and 30 years. Participants underwent comprehensive 528 
clinical, cognitive, and MRI assessment at one of the following five centers: Institute of 529 
Psychiatry, Psychology and Neuroscience, King’s College London, United Kingdom; Autism 530 
Research Centre, University of Cambridge, United Kingdom; Radboud University Nijmegen 531 
Medical Centre, the Netherlands; University Medical Centre Utrecht, the Netherlands; and 532 
Central Institute of Mental Health, Mannheim, Germany. The study was approved by the local 533 
ethical committees of participating centers (see Supplementary Table 2), and written informed 534 
consent was obtained from all participants or their legal guardians (for participants <18 years). 535 
For further details about the study design, we refer to Loth et al.,20, and for a comprehensive 536 
clinical characterization of the LEAP cohort, we refer to Charman et al.,19. In the present study, 537 
we selected all participants for whom structural and rsfMRI data were available. However, 538 
n=120 participants had to be excluded from the analysis because of missing ADI-R item-level 539 
data (n=64), missing IQ data (n=3), or because preprocessing could not be completed for a 540 
variety of reasons (e.g., registration/normalization errors because of poor quality MPRAGE data, 541 
poor anatomical coverage, or large anatomical deviance such as large ventricles (n=39), 542 
incomplete rsfMRI data (n=3), errors in convergence of the ME-ICA algorithm (n=11)). The 543 
final sample size was n=266 autistic and n=243 TD participants. This final sample was split into 544 
independent Discovery and Replication sets (balanced for sex and age) for the purpose of 545 
identifying functional connectivity differences that are replicable. As an example of sample sizes 546 
once split into autism subtypes at a z-threshold of 1, within the Discovery set there were n=77 547 
SC=RRB, n=50 SC>RRB, and n=121 TD individuals. Within the Replication set there were 548 
n=83 SC=RRB, n=49 SC>RRB, and n=122 TD individuals. N=7 (n=6 Discovery, n=1 549 
Replication) were classified as RRB>SC and because the sample sizes were too small, we did not 550 
analyze this subtype further for functional connectivity differences. We tested subtypes on a 551 
variety of different phenotypic measures including the ADOS-2, Social Responsiveness Scale 552 
(SRS-2), Repetitive Behavior Scale (RBS-R), Short Sensory Profile (SSP) and the Vineland 553 
Adaptive Behavior Scales (VABS). See Table 2 for participant characteristics. 554 
 555 




MRI data were acquired on 3T scanners: General Electric MR750 (GE Medical Systems, 558 
Milwaukee, WI, USA) at Institute of Psychiatry, Psychology and Neuroscience, King’s College 559 
London, United Kingdom (KCL); Siemens Magnetom Skyra (Siemens, Erlangen, Germany) at 560 
Radboud University Nijmegen Medical Centre, the Netherlands (RUMC); Siemens Magnetom 561 
Verio (Siemens, Erlangen, Germany) at the University of Cambridge, United Kingdom 562 
(UCAM); Philips 3T Achieva (PhilipsHealthcare Systems, Best, The Netherlands) at University 563 
Medical Centre Utrecht, the Netherlands (UMCU); and Siemens Magnetom Trio (Siemens, 564 
Erlangen, Germany) at Central Institute of Mental Health, Mannheim, Germany (CIMH). 565 
Procedures were undertaken to optimize the MRI sequences for the best scanner-specific options, 566 
and phantoms and travelling heads were employed to assure standardization and quality 567 
assurance of the multi-site image-acquisition19. Structural images were obtained using a 5.5 568 
minute MPRAGE sequence (TR=2300ms, TE=2.93ms, T1=900ms, voxels size=1.1x1.1x1.2mm, 569 
flip angle=9°, matrix size=256x256, FOV=270mm, 176 slices). An eight-to-ten minute resting-570 
state fMRI (rsfMRI) scan was acquired using a multi-echo planar imaging (ME-EPI) 571 
sequence31,32; TR=2300ms, TE~12ms, 31ms, and 48ms (slight variations are present across 572 
centers), flip angle=80°, matrix size=64x64, in-plane resolution=3.8mm, FOV=240mm, 33 axial 573 
slices, slice thickness/gap=3.8mm/0.4mm, volumes=200 (UMCU), 215 (KCL, CIMH), or 265 574 
(RUMC, UCAM). Participants were instructed to relax, with eyes open and fixate on a cross 575 
presented on the screen for the duration of the rsfMRI scan. 576 
 577 
EU-AIMS LEAP fMRI Preprocessing 578 
 579 
Multi-echo rsfMRI data were preprocessed with the multi-echo independent components 580 
analysis (ME-ICA) pipeline, implemented with the meica python library (v3.2) 581 
(https://github.com/ME-ICA/me-ica). ME-ICA implements both basic fMRI image 582 
preprocessing and decomposition-based denoising that is specifically tailored for multi-echo EPI 583 
data. For the processing of each subject, first the anatomical image was skull-stripped and then 584 
warped nonlinearly to the MNI anatomical template using AFNI 3dQWarp. The warp field was 585 
saved for later application to functional data. For each functional dataset, the first TE dataset was 586 
used to compute parameters of motion correction and anatomical-functional coregistration, and 587 
the first volume after equilibration was used as the base EPI image. Matrices for de-obliquing 588 
and six-parameter rigid body motion correction were computed. Then, 12-parameter affine 589 
anatomical-functional coregistration was computed using the local Pearson correlation (LPC) 590 
cost functional, using the gray matter segment of the EPI base image computed with AFNI 591 
3dSeg as the LPC weight mask. Matrices for de-obliquing, motion correction, and anatomical-592 
functional coregistration were combined with the standard space nonlinear warp field to create a 593 
single warp for functional data. The dataset of each TE was then slice-time corrected and 594 
spatially aligned through application of the alignment matrix, and the total nonlinear warp was 595 
applied to the dataset of each TE. No time-series filtering was applied in the preprocessing 596 
phase. No spatial smoothing was applied during preprocessing. 597 
 598 
The preprocessed multi-echo time-series datasets were then used by the ME-ICA pipeline 599 
to leverage information in the multiple echoes to compute an optimal weighting of TE at each 600 
voxel33, producing an ‘optimally combined’ time-series dataset. This optimal combination 601 
procedure has been shown to double temporal signal-to-noise ratio (tSNR) over traditional single 602 
echo EPI data34. This preprocessed optimally combined time-series dataset was then fed into a 603 
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denoising procedure based on independent components analysis (ICA) and scoring components 604 
by ρ and κ pseudo-F statistics that indicate degree of TE-independence or TE-dependence. 605 
Components with high ρ and low κ are components high in non-BOLD related contrast (i.e. non-606 
BOLD artefact signal), while components with high κ and low ρ indicate components high in 607 
BOLD-related contrast. ME-ICA identifies in an automated fashion high ρ and low κ non-BOLD 608 
components and removes them from the optimally combined time-series dataset to produce the 609 
final multi-echo denoised dataset. This procedure has been shown to be very effective in 610 
removing various types of non-BOLD artefact from rsfMRI data, including head motion artefact, 611 
flattens DVARS traces induced by head motion, and increases tSNR by a factor of 4 over and 612 
above traditional single echo EPI data31,32,34,35. The final multi-echo denoised datasets were used 613 
in further connectivity analyses. Head motion estimates and DVARS were estimated in order to 614 
show the impact of denoising on reducing non-BOLD artefact due to head motion (see 615 
Supplementary Figure 3 for examples). In the EU-AIMS LEAP data, groups did not differ in 616 
mean FD (see Table 2). 617 
 618 
EU-AIMS LEAP Functional Connectivity Analyses 619 
 620 
To assess large-scale intrinsic functional organization of the brain we input the multi-621 
echo denoised data into a group-ICA analysis. Dual regression was then utilized to back-project 622 
spatial maps and individual time-series for each component and subject. Both group-ICA and 623 
dual regression were implemented with FSL’s MELODIC and Dual Regression tools 624 
(www.fmrib.ox.ac.uk/fsl). For group-ICA, we constrained the dimensionality estimate to 30. Of 625 
the 30 final components, 11 were discarded after visual examination of spatial maps which 626 
indicated that they did not correspond to well-known rsfMRI networks and instead resembled 627 
white matter or other artefacts36. See Supplementary Figure 4 for visual depiction of the 19 ICs 628 
used in further analysis. 629 
 630 
Time courses for each subject and each independent component (IC) were used to model 631 
between-component connectivity. This was achieved by constructing a partial correlation matrix 632 
amongst all 19 components using Tikhonov-regularization (i.e. ridge regression, rho=1) as 633 
implemented within the nets_netmats.m function in the FSLNets MATLAB toolbox  634 
(https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSLNets). The aim of utilizing partial correlations was to 635 
estimate direct connection strengths in a more accurate manner than can be achieved with full 636 
correlations, which allow more for indirect connections to influence connectivity strength37–39. 637 
Partial correlations were then converted into Z-statistics using Fisher’s transformation for further 638 
statistical analyses. The lower diagonal of each subject’s partial correlation matrix was extracted 639 
for a total of 171 separate component-pair comparisons.  640 
 641 
To identify replicable subtype effects on functional connectivity, we partitioned the EU-642 
AIMS LEAP dataset into Discovery and Replication sets. This was achieved via a random half 643 
split of the subtypes within each scanning site and balancing for sex. TD comparison groups for 644 
Discovery and Replication sets were also selected via a random split balancing sex and achieving 645 
an age-match (achieved using the MatchIt library in R with the default method of nearest 646 
neighbor matching). Models implementing the main hypothesis tests of subtype differences were 647 
computed as linear mixed effect models (lme function from the nlme library in R), whereby 648 
connectivity was the dependent variable, and subtype, sex, and age were used as fixed effect 649 
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independent variables and site was modeled with random intercepts as a random effect. These 650 
models were computed separately for the Discovery and Replication set. Connectivity pairs were 651 
deemed as showing replicable subtype differences if the Discovery set showed an effect at 652 
p<0.05 and the replication Bayes Factor statistic40 computed on t-statistics from Discovery and 653 
Replication sets was greater than 10 (repBF>10), indicating strong evidence in favor of 654 
replication.  655 
 656 
Because subtyping depends on the choice of a z-threshold, we ran the connectivity 657 
analyses across a range of z-thresholds from z=0.5 to z=1, moving up in steps of 0.1. Across all 658 
these z-thresholds, we identified ‘consensus edges’, defined as replicable subtype connectivity 659 
differences that appear at all z-thresholds. These edges are focused since they are the robust 660 
subtype connectivity differences that are not dependent on a particular z-threshold for labeling 661 
the subtypes. For each threshold, we also counted up the number of edges that are common 662 
across subtypes and with similar directionality in order to estimate how often subtypes show 663 
similar functional connectivity differences. 664 
 665 
To contrast the subtyping approach to a more dimensional approach where z-normalized 666 
SC-RRB differences scores are left continuous, we also ran similar mixed effect models where 667 
these continuous scores are the primary independent variable of interest rather than the subtype 668 
variable. Because the z-normalized difference score does not capture overall severity level well 669 
(e.g., an individual with low SC and RBB has a difference near 0 just like an individual with 670 
high SC and RRB), we also ran models whereby continuous SC or RRB scores were used as 671 
independent variables rather than the z-normalized difference score. This allowed for another 672 
contrast to test if overall level of severity within each domain could explain connectivity 673 
strength. In each of these dimensional models, the same criteria for identifying replicable effects 674 
in the subtype models was used (e.g., p<0.05 in the Discovery set and a repBF > 10).   675 
 676 
Gene expression decoding analyses 677 
 678 
 To identify genes whose spatial expression pattern is similar to subtype-specific ICs, we 679 
used the Gene Expression Decoding feature embedded within Neurosynth23 to identify genes that 680 
are statistically similar in their expression profile in a consistent manner across all 6 donor brains 681 
within the Allen Institute Human Brain Atlas22. The analysis first utilizes a linear model to 682 
compute similarity between the observed rsfMRI IC map and spatial patterns of gene expression 683 
for each of the six brains in the Allen Institute dataset. The slopes of these subject-specific linear 684 
models encode how similar each gene’s spatial expression pattern is with our rsfMRI IC maps. 685 
These slopes were then subjected to a one-sample t-test to identify genes whose spatial 686 
expression patterns are consistently of high similarity across the donor brains to the rsfMRI IC 687 
maps we input. This analysis was restricted to cortical tissue since all of the networks being 688 
analyzed are primarily cortical. The resulting list of genes was then thresholded for multiple 689 
comparisons and only the genes surviving FDR q < 0.05 and also had a positive t-statistic value 690 
were considered. 691 
 692 




 To test if network-associated genes were enriched for different classes of autism-695 
associated genes we first curated a list of genes known at genetic and transcriptomic levels to be 696 
associated with autism. At the genetic level, we utilized the list of 102 genes reported by 697 
Satterstrom et al.,41 that are rare de novo protein truncating variants that are associated with a 698 
diagnosis of autism (ASD dnPTV). A second list of autism-associated genes (ASD SFARI) at the 699 
genetic level was the list curated by SFARI Gene (https://gene.sfari.org/). We utilized the entire 700 
list of genes in categories S, 1, 2, and 3 for these analyses (downloaded on July 16, 2020). At the 701 
transcriptomic level we used several lists. First, we used a list of differentially expressed genes in 702 
autism post-mortem frontal and temporal cortex tissue from Gandal et al.,42 and this list was 703 
further split by genes that were downregulated (ASD DE Downreg) or upregulated (ASD DE 704 
Upreg) in autism. To contrast these enrichments with other psychiatric diagnoses that are 705 
genetically correlated with autism, we also use differentially expressed genes in schizophrenia 706 
(SCZ DE) and bipolar disorder (BD DE), identified from the same Gandal et al., study42. To go 707 
beyond differentially expressed genes in bulk tissue samples, we also examined autism 708 
differentially expressed genes identified in specific cell types - particularly, excitatory (ASD 709 
Excitatory) and inhibitory (ASD Inhibitory) neurons, microglia (ASD Microglia), astrocytes 710 
(ASD Astrocyte), oligodendrocytes (Oligodendrocyte), and endothelial (ASD Endothelial) 711 
cells43. Beyond differentially expressed genes, we utilized all genes identified in frontal and 712 
temporal cortical tissue that were members of co-expression modules identified to be 713 
downregulated (ASD CTX Downreg CoExpMods) or upregulated (ASD CTX Upreg 714 
CoExpMods) in autism44. All tests of enrichment were conducted with custom code written in R 715 
that computes enrichment odds ratios and p-values based on hypergeometric tests. The 716 
background total for these enrichment tests was set to 20,787, which is the total number of genes 717 
considered by the gene expression decoding analysis in Neurosynth. FDR was computed 718 
amongst all of the enrichment tests done and only tests that survived FDR q < 0.05 were 719 
interpreted further as statistically significant enrichments. 720 
 721 
Data availability, statistics, and reproducibility 722 
 723 
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Figure Legends 1015 
 1016 
Figure 1: Approach towards testing common pathway versus multiple pathways explanations 1017 
behind SC-RRB balance in autism. In this figure we depict two alternatives for how SC-RRB 1018 
balance subtypes (phenome level; SC=RRB, green; RRB>SC, pink; SC>RRB, blue) could be 1019 
explained at the level of macroscale functional connectome phenotypes measured with rsfMRI 1020 
(connectome level) and autism-associated functional genomic mechanisms (e.g., transcriptome 1021 
and genome levels). Columns in this figure depict the common pathway (middle) and multiple 1022 
pathways (right) models. The common pathway model predicts that when each subtype is 1023 
compared to a typically-developing (TD) comparison group, they converge and share a common 1024 
difference from TD in affected macroscale rsfMRI functional connectome phenotype. 1025 
Underpinning this shared connectome phenotype are a myriad of differing functional genomic 1026 
mechanisms. At the level of the transcriptome, we identify genes linked to macroscale functional 1027 
networks by identifying genes whose spatial expression pattern across the brain is similar to the 1028 
spatial topology of the macroscale functional network. This procedure generates a list of genes 1029 
relevant for such macroscale networks and these lists are then tested for enrichment in autism-1030 
association functional genomic mechanisms. The gene list at the genome level represents an 1031 
example of possible autism-associated genes that may (bold) or may not (non-bold) be linked to 1032 
macroscale functional networks. In contrast to the common pathway model, the multiple 1033 
pathways model would highlight that differential connectome phenotypes when compared to TD 1034 
are unique to each subtype, and that each of these subtype-specific connectome phenotypes is 1035 
underpinned by a differing set of autism-associated functional genomic mechanisms. 1036 
 1037 
 1038 
Figure 2: Supervised subtyping of autism by SC-RRB balance. Panel A shows the subtypes 1039 
derived from a z-normalized difference score of SC-RRB, with a z-score threshold for cutting the 1040 
subtypes at z = 1. Red shows the RRB>SC subtype, green shows the SC=RRB subtype, and blue 1041 
shows the SC>RRB subtype. Panel B shows a confusion matrix with actual subtype labels for the 1042 
NDAR Replication dataset along the columns and the subtyping model’s predicted labels 1043 
(trained on the NDAR Discovery dataset) along the rows. The colors within the cells indicate the 1044 
percentage of individuals relative to the actual labels with predicted labels in each cell. Over a 1045 
range of z-thresholds from 0.5 to 1, the accuracy ranged from 97-99% accuracy. Panel C shows 1046 
SC-RRB subtypes from the EU-AIMS LEAP datasets derived using norms estimated from NDAR.  1047 
 1048 
 1049 
Figure 3: Replicable subtype differences in functional connectivity. This figure shows chord 1050 
diagrams of replicable functional connectivity differences between SC=RRB vs TD (left) or 1051 
SC>RRB vs TD (right), when subtypes are defined at a z-threshold of 1. However, edges shown 1052 
in these diagrams are consensus edges that appear in every analysis of connectivity differences 1053 
irrespective of the z-threshold used to define the subtypes. Red edges indicate hyperconnectivity 1054 
in the autism subtype relative to TD, while blue edges indicate hypoconnectivity in autism 1055 
subtype relative to TD. Intensity of edge color indicates standardized effect size (Cohen’s d) 1056 
shown on the colorbar on the right. The cortical surface renderings of each component are 1057 
unthresholded z-stat maps. Areas with higher z-stats (dark red) are of primary importance for 1058 
 
 27
the IC map. The top row shows effects in the EU-AIMS LEAP Discovery set, while bottom row 1059 
shows effects in the EU-AIMS LEAP Replication set. 1060 
 1061 
 1062 
Figure 4: Overlap between genes expressed in functional connectivity networks and genes 1063 
linked to autism. In panel A we depict the analysis approach of identifying genes which are 1064 
highly expressed in similar spatial patterns to the rsfMRI spatial IC maps (i.e. gene expression 1065 
decoding). Once IC gene lists have been identified, we test these lists for enrichment with known 1066 
lists of autism-associated functional genomic mechanisms (top left). In panel B we show 1067 
enrichment odds ratios (numbers in each cell) along with the -log10 p-value (coloring of the 1068 
cells) for enrichment tests of specific networks (columns) against known lists of autism-1069 
associated genomic mechanisms (rows). Cells outlined with thick black rectangles survive FDR 1070 
q<0.05. The column labeled SC>RRB shows the enrichment results when the gene list under 1071 
consideration comprises genes unique to IC17, but not any of the other ICs. The column labeled 1072 
SC=RRB shows the enrichment results when the gene list under consideration consists of genes 1073 
unique to IC03, IC07, and IC13, but not IC12 or IC17. ASD dnPTV, Autism de novo protein 1074 
truncating variants; ASD SFARI, SFARI Gene autism associated genes; ASD DE Downreg, 1075 
autism differentially expressed downregulated genes; ASD DE Upreg, autism differentially 1076 
expressed upregulated genes; ASD CTX Downreg CoExpMods, autism downregulated cortical 1077 
co-expression modules; ASD CTX Upreg CoExpMods, autism upregulated cortical co-1078 
expression modules; ASD Excitatory, autism differentially expressed genes in excitatory 1079 
neurons; ASD Inhibitory, autism differentially expressed genes in inhibitory neurons; ASD 1080 
Microglia, autism differentially expressed genes in microglia; ASD Oligodendrocyte, autism 1081 
differentially expressed genes in oligodendrocytes; ASD Astrocyte, autism differentially 1082 
expressed genes in astrocytes; ASD Endothelial, autism differentially expressed genes in 1083 
endothelial cells; SCZ DE, schizophrenia differentially expressed genes; BD DE, bipolar 1084 
disorder differentially expressed genes. 1085 
 1086 
 1087 
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Table 1: Participant characteristics from the NDAR datasets. At a z-threshold of 1, this table shows sample sizes 1092 
and descriptive statistics (mean and standard deviation) for age and ADOS social affect (SA) and restricted 1093 
repetitive behaviors (RRB) calibrated severity scores. The final column on the right shows the F-statistic and p-1094 
value from an ANOVA testing for an effect of group. i Sample sizes: ADOS (Discovery, RRB>SC n=19, SC=RRB 1095 
n=99, SC>RRB n=35; Replication RRB>SC n=8, SC=RRB n=119, SC>RRB n=26); FIQ (Discovery, RRB>SC 1096 
n=39, SC=RRB n=142, SC>RRB n=18; Replication RRB>SC n=40, SC=RRB n=135, SC>RRB n=11). 1097 
Abbreviations: FIQ = full-scale IQ; ADI-R = Autism Diagnostic Interview Revised; ADOS = Autism Diagnostic 1098 
Observation Schedule; SC = social-communication; RRB = restricted repetitive behaviors; SA = social affect; CSS 1099 
= calibrated severity score. ii DSM-5 domain percentage scores used for the SC-RRB difference score computation.  1100 




 Discovery Replication 
 SC>RRB SC=RRB RRB>SC TD F (p-val) SC>RRB SC=RRB RRB>SC TD F (p-val) 
N 
(male) 
50 (36) 77 (59) 6 (3) 121 
(80) 
























































































































































































































































































































































Table 2: Participant characteristics from the EU-AIMS LEAP dataset. At a z-threshold of 1, this table shows 1104 
sample sizes and descriptive statistics alongside F-statistic and p-value from an ANOVA testing for an effect of 1105 
group. For ADI-R, ADOS, SRS, RBS, SSP, and VABS, the F-statistic and p-value refer to a group difference between 1106 
SC=RRB vs SC>RRB, while for age, mean FD, and FIQ, the F-statistic and p-value refer to a model that takes into 1107 
account all groups. i Sample sizes: ADOS (Discovery, RRB>SC n=6, SC=RRB n=76, SC>RRB n=48; Replication 1108 
RRB>SC n=1, SC=RRB n=81, SC>RRB n=46); SRS (Discovery, RRB>SC n=3, SC=RRB n=67, SC>RRB n=44, 1109 
TD n=68; Replication RRB>SC n=1, SC=RRB n=76, SC>RRB n=41, TD n=65); RBS (Discovery, RRB>SC n=3, 1110 
SC=RRB n=64, SC>RRB n=43, TD n=68; Replication RRB>SC n=1, SC=RRB n=73, SC>RRB n=41, TD n=63); 1111 
SSP (Discovery, RRB>SC n=2, SC=RRB n=44, SC>RRB n=33, TD n=59; Replication RRB>SC n=1, SC=RRB 1112 
n=50, SC>RRB n=32, TD n=54); Vineland (Discovery, RRB>SC n=4, SC=RRB n=74, SC>RRB n=45, TD n=34; 1113 
Replication RRB>SC n=1, SC=RRB n=76, SC>RRB n=44, TD n=39). Abbreviations: FD = framewise 1114 
displacement; FIQ = full-scale IQ; ADI-R = Autism Diagnostic Interview Revised; ADOS = Autism Diagnostic 1115 
Observation Schedule; SC = social-communication; RRB = restricted repetitive behaviors; SA = social affect; CSS 1116 
= calibrated severity score; SRS = Social Responsiveness Scale; RBS = Repetitive Behavior Scale; SSP = Short 1117 
Sensory Profile; VABS = Vineland Adaptive Behavior Scales; Comm = Communication; DLS = Daily Living Skills; 1118 
Soc = Socialization; ABC = Adaptive Behavior Composite. ii DSM-5 domain percentage scores used for the SC-RRB 1119 
difference score computation.  1120 




